The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oaktree Releases Open Letter to Shareholders: Changed Landscape Reinforces Need for Board Change

12 Jun 2018 07:00

Funds managed by Oaktree Capital Management, L.P. (“Oaktree”), an approximately 19% shareholder of Ranger Direct Lending Fund PLC (LON: RDL) (“Ranger” or “RDLF” or “the Company”), today released an open letter to Ranger shareholders.

The full text of the letter follows:

June 11, 2018

Dear fellow Ranger shareholders,

The Ranger Board announced today that Ares has withdrawn its proposal to be appointed the Company's investment manager and that the Board will now pursue a wind-down. We are pleased that the significant shareholder support for Board change has led Ares to withdraw their proposal and the Board to come to the conclusion that realizing the assets of the Company in an orderly manner is the best way to protect shareholder value.

Board change is imperative for proper oversight of value-maximizing wind-down

Oaktree believes that, now more than ever, new directors are needed to maximize shareholder value in the wind-down. Even the Board has conceded that it will need to appoint additional independent non-executive Directors to oversee the wind-down “following consultation with shareholders”. We urge the Board to put the interest of shareholders first and do the right thing by immediately entering into discussion with Oaktree to add Oaktree’s nominees instead of continuing with a costly, distracting and misguided effort to block highly-qualified, shareholder-supported nominees.

Oaktree’s nominees, Dominik Dolenec and Greg Share, provide much-needed additional oversight and experience to this complex process. Messrs. Share and Dolenec have a combined 40 years of experience in specialty finance, restructuring, and litigation (see Exhibit 1), which will be critical to overseeing an effective and efficient wind-down that maximizes shareholder returns. With the right decision finally having been made to wind down and the voice of shareholders recognized, the most efficient way to ensure success is to elect our nominees at the upcoming meeting.

Shareholders now have the opportunity to elect new, independent and qualified nominees to the Board of Directors, and can do so in a transparent manner without relying on the existing Ranger Board.

The Annual General Meeting takes place on Tuesday, June 19, 2018, and it is important to vote on or before Friday, June 15, 2018 to have your voice heard. We urge shareholders to act now to add the necessary oversight and experience to the Board at such a crucial time for the Company – vote FOR resolutions 8 and 9 for Oaktree’s highly qualified nominees, Greg Share and Dominik Dolenec.

If shareholders have questions, or need assistance in voting shares, please call: Georgeson, +44 (0) 207 019 7032 or email anthony.kluk@georgeson.com.

Sincerely,/s/ Patrick M. McCaneyPatrick M. McCaneyManaging Director and Portfolio ManagerValue EquitiesOaktree Capital Management, L.P.

Exhibit 1

Specialty Finance

Asset Recovery / Restructuring

Litigation

Oaktree Nominees

Dominik Dolenec Managing Partner and Founder of Emona Capital, a London-based investment and advisory firm. Over 20 years of investment and advisory experience, including complex restructurings and turnarounds, financings and other corporate events. Deep knowledge and investment experience across European and US direct lending platforms Formerly investor and board member of IFG Group, an invoice finance platform and an RDL investee platform Investor and board observer of TransferGo, a digital remittance payment platform Led several stressed and distressed credit investments at Elliott Advisors, a global special situation hedge fund with $36 billion of AUM Acted as Chief Restructuring Officer at Brunswick Rail Ltd., with over $700 million of corporate liabilities outstanding Involved in a number of litigation strategies that formed part of creditor restructurings and other special situation investments at Elliott Advisors
Greg Share Managing Partner and Co-Founder of Ambina Partners, LLC, which invests in software and financial services companies. Prior roles include leadership positions at Moelis, Fortress and Madison Dearborn where he focused on the software and financial services sectors. Deep knowledge and investment experience of direct lending platforms Former Managing Director of Fortress Investment Group, an entity with several direct lending platforms Founding investor and board observer of MidCap Financial, a healthcare focused lending platform grown from start-up and sold to Apollo Global Management Experience maximizing proceeds from businesses in liquidation or run-off Executed successful strategy as investor and director of Boxclever Ltd, a UK TV rental business purchased in receivership Managed run-off of Alea Group Ltd, a multinational insurer with over $2 billion of assets

Company Nominees

Christopher Waldron Chair; 30 years’ experience as asset manager X V X
Dr Matthew Mulford HEC-Paris professor; LSE senior research fellow X X X
Jonathan Schneider Entrepreneur and investor V V X
K Scott Canon Founder and CEO of Ranger Capital X X X

About Oaktree

Oaktree is a leader among global investment managers specializing in alternative investments, with $121 billion in assets under management as of March 31, 2018. The firm emphasizes an opportunistic, value-oriented and risk-controlled approach to investments in credit, private equity, real assets and listed equities. The firm has over 900 employees and offices in 18 cities worldwide. For additional information, please visit Oaktree’s website at http://www.oaktreecapital.com/.

Sard Verbinnen & CoJohn Christiansen, +1-415-618-8750jchristiansen@sardverb.comorConrad Harrington+44 (0) 20 3178 8914charrington@sardverb.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180611006000/en/

Copyright Business Wire 2018

Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.